Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Progress in the fight against the HIV/AIDS epidemic is hindered by our failure to elucidate the precise reasons for the onset of immunodeficiency in HIV-1 infection. Increasing evidence suggests that elevated immune activation is associated with poor outcome in HIV-1 pathogenesis. However, the basis of this association remains unclear. Through ex vivo analysis of virus-specific CD8(+) T-cells and the use of an in vitro model of naïve CD8(+) T-cell priming, we show that the activation level and the differentiation state of T-cells are closely related. Acute HIV-1 infection induces massive activation of CD8(+) T-cells, affecting many cell populations, not only those specific for HIV-1, which results in further differentiation of these cells. HIV disease progression correlates with increased proportions of highly differentiated CD8(+) T-cells, which exhibit characteristics of replicative senescence and probably indicate a decline in T-cell competence of the infected person. The differentiation of CD8(+) and CD4(+) T-cells towards a state of replicative senescence is a natural process. It can be driven by excessive levels of immune stimulation. This may be part of the mechanism through which HIV-1-mediated immune activation exhausts the capacity of the immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Terminally differentiated (CD28−CD57+) T lymphocytes are characterized by strong effector functions such as expression of cytotoxins (e.g., Perforin and Granzyme B) and cytolytic capacity, and a marked inflammatory profile by way of increase proinflammatory cytokine (e.g., IFN-γ, TNF-α, MIP-1β) secretion [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Experimental — accuracy not yet measuredIn the citing paper
“The increased proportion of terminally differentiated oligoclonal effector memory T-cell populations in the elderly has been shown to be the consequence of recurrent or chronic immune activation [86].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
In the citing paper
“However, terminally differentiated T cells are constrained by limited proliferative capabilities in tandem with short telomeres, and to a large extent, have been defined as approaching senescence [86, 87].”
From Aging of the immune system: Focus on inflammation and vaccination (2016) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544 · cited 1×
“HLA–peptide tetrameric complexes (‘‘tetramers’’) were produced as previously described (Altman et al. 1996) and included the following specificity: A2 HIV p17-SLYNTVATL and pol-ILKEPVHGV, A2 CMV pp65-NLVPMVATV, A2 EBV BMLF1-GLCTLVAML, A2 influenza matrix-GILGFVFTL, A2 melanA-ELAGIGILTV, B7 HIV nef-TPGPGVRYPL and gp41-…”
MethodSelf-citationKoup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495 · cited 1×
“During primary human immunodeficiency virus 1 (HIV-1) infection, the immune system appears to respond appropriately in order to prevent viral spread, with the mounting of a strong HIV-specific CD8þ T-cell response and a corresponding reduction in viraemia (Koup et al. 1994).”
BackgroundCounting Antigen-Specific CD8 T Cells: A Reevaluation of Bystander Activation during Viral Infection
Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J. D., Zajac, A. J., Miller, J. D., Slansky, J., & Ahmed, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80470-7 · Cited by 1,943 · cited 1×
“T-cell compartment. Our data indicate that HIV-1 infection results in immune activation not only directly, but also indirectly, with the activation of cells specific for non-HIV antigens. In recent years, the role of potential bystander activation has been reevaluated and is now considered less important (”
BackgroundChanges in thymic function with age and during the treatment of HIV infection
Douek, D. C., McFarland, R. D., Keiser, P. H., Gage, E. A., Massey, J. M., Haynes, B. F., Polis, M. A., Haase, A. T., Feinberg, M. B., Sullivan#, J. L., et al. (1998) · Nature · doi:10.1038/25374 · Cited by 1,893 · cited 1×
“2002c), HIV-infected individuals are characterised by decreased thymic output (Douek et al. 1998) and reduced naı̈ve T-cell numbers (Roederer et al.”
BackgroundLineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864 · cited 1×
“’’ Protective immunity has recently been associated with the proliferative capacity of virus-specific CD8 T-cells in the mouse model (Wherry et al. 2003).”
BackgroundMemory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M. A., Papagno, L., Ogg, G. S., King, A., Lechner, F., Spina, C. A., et al. (2002) · Nature Medicine · doi:10.1038/nm0402-379 · Cited by 1,571 · cited 13×
“One could speculate that the association between different stages of CD8þ T-cell differentiation and viral specificity of these cells, as previously described (Appay et al. 2002a; Tussey et al. 2003), may be related to the stimulation intensity received by the cells from priming onwards.”
BackgroundMethodInfluentialSelf-citationPhenotypic and functional separation of memory and effector human CD8+ T cells
Hamann, D., Baars, P. A., Rep, M. H. G., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., & Lier, R. A. W. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1407 · Cited by 1,366 · cited 1×
“The assumption that CD28 /CD27 T-cells are protective effector cells is mainly based on the fact that these cells possess strong cytotoxic potential, expressing high levels of perforin, as seen ex vivo (Hamann et al. 1997).”
BackgroundBorrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183 · cited 1×
“Continuous adaptive mutation (Borrow et al. 1997) and destruction or impairment of elements necessary for an optimal immune response (e.”
BackgroundBrenchley, J. M., Karandikar, N. J., Betts, M. R., Ambrozak, D. R., Hill, B. J., Crotty, L. E., Casazza, J. P., Kuruppu, J., Migueles, S. A., Connors, M., et al. (2003) · Blood · doi:10.1182/blood-2002-07-2103 · Cited by 1,073 · cited 4×
“…following priming of T-cells in vitro (see Figure 2C), although this remained relatively modest (below 10%), possibly due to the high susceptibility to activation induced cells death of CD57þ Tcells (Brenchley et al. 2003; unpublished data) in the interleukin-2 (IL-2)-supplemented assay conditions.”
BackgroundInfluentialMigueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005 · cited 1×
“This is supported by Migueles et al. (2002), who showed that HIV-1-infected long-term nonprogressors are characterised by HIV-1-specific CD8þ T-cells that maintain a strong proliferative capacity following in vitro stimulation (cells defined mainly as CD45ROþ/CD28þ/CD27þ early-differentiated cells).”
Background
Research works printed but not linked: 3
- Gerna, 1998, New Microbiol, 21, 293
- Giorgi, 1993, J Acquir Immune Defic Syndr, 6, 904
- Hellerstein, 2003, J Clin Invest, 112, 956, 10.1172/JCI200317533 · doi:10.1172/jci200317533 · Paper page
Cited by
Climate Change and Infectious Diseases: From Evidence to a Predictive Framework
Altizer, S., Ostfeld, R. S., Johnson, P. T. J., Kutz, S., & Harvell, C. D. (2013) · Science · doi:10.1126/science.1239401 · Cited by 1,292
Gattinoni, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24480 · Cited by 958
“The incidence of IFN-γ+perforinhigh HIV-specific CD8+ T cells has been reported to correlate with HIV-1 disease progression (49, 50).”
BackgroundSystemic Effects of Inflammation on Health during Chronic HIV Infection
Deeks, S. G., Tracy, R., & Douek, D. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.001 · Cited by 868
“…the frequency of HIVspecific T cells is only a small proportion of the activated cell population, suggesting other less-direct mechanisms) (Papagno et al., 2004); (2) other pathogens—including common herpes viruses such as CMV—contribute to high level T cell activation, although why the…”
InfluentialAdoptive immunotherapy for cancer: building on success
Gattinoni, L., Powell, D. J., Rosenberg, S. A., & Restifo, N. P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1842 · Cited by 845
The Influence of Age on T Cell Generation and TCR Diversity
Naylor, K., Li, G., Vallejo, A. N., Lee, W.-W., Koetz, K., Bryl, E., Witkowski, J., Fulbright, J., Weyand, C. M., & Goronzy, J. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7446 · Cited by 802
Immune activation and inflammation in HIV‐1 infection: causes and consequences
Appay, V, & Sauce, D. (2008) · The Journal of Pathology · doi:10.1002/path.2276 · Cited by 743
“Recent studies have shown significant activation of EBV- and CMV-specific CD8+ T cells during HIV1 acute infection [40,41].”
BackgroundInfluentialSelf-citationBjörkström, N. K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M. A., Björklund, A. T., Flodström-Tullberg, M., Michaëlsson, J., Rottenberg, M. E., et al. (2010) · Blood · doi:10.1182/blood-2010-04-281675 · Cited by 734
Phenotype and function of human T lymphocyte subsets: Consensus and issues
Appay, V., van Lier, R. A. W., Sallusto, F., & Roederer, M. (2008) · Cytometry Part A · doi:10.1002/cyto.a.20643 · Cited by 729
“tive histories as well as proliferative potentials (19,32,33).”
BackgroundSelf-citationAlmeida, J. R., Price, D. A., Papagno, L., Arkoub, Z. A., Sauce, D., Bornstein, E., Asher, T. E., Samri, A., Schnuriger, A., Theodorou, I., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070784 · Cited by 714
Self-citationSáez-Cirión, A., Lacabaratz, C., Lambotte, O., Versmisse, P., Urrutia, A., Boufassa, F., Barré-Sinoussi, F., Delfraissy, J.-F., Sinet, M., Pancino, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611244104 · Cited by 616
Serrano-Villar, S., Sainz, T., Lee, S. A., Hunt, P. W., Sinclair, E., Shacklett, B. L., Ferre, A. L., Hayes, T. L., Somsouk, M., Hsue, P. Y., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004078 · Cited by 611
“Many of the immunologic abnormalities that persist during therapy are similar to those observed in the elderly, raising the hypothesis that age-associated decline in immune function (‘‘immunosenescence’’) contributes to disease progression and adverse outcomes [13–16].”
BackgroundPaths to stemness: building the ultimate antitumour T cell
Gattinoni, L., Klebanoff, C. A., & Restifo, N. P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3322 · Cited by 599
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
CD8 + T‐cell memory in tumor immunology and immunotherapy
Klebanoff, C. A., Gattinoni, L., & Restifo, N. P. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00391.x · Cited by 511
“(76, 88, 89), a decrease in telomere length (87), and an”
BackgroundStrioga, M., Pasukoniene, V., & Characiejus, D. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03470.x · Cited by 505
Antigen-independent memory CD8 T cells do not develop during chronic viral infection
Wherry, E. J., Barber, D. L., Kaech, S. M., Blattman, J. N., & Ahmed, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407192101 · Cited by 497
HIV and SIV CTL escape: implications for vaccine design
Goulder, P. J. R., & Watkins, D. I. (2004) · Nature Reviews Immunology · doi:10.1038/nri1417 · Cited by 500
HIV‐associated chronic immune activation
Paiardini, M., & Müller‐Trutwin, M. (2013) · Immunological Reviews · doi:10.1111/imr.12079 · Cited by 451
Antiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 449
Aging of the immune system: Focus on inflammation and vaccination
Pinti, M., Appay, V., Campisi, J., Frasca, D., Fülöp, T., Sauce, D., Larbi, A., Weinberger, B., & Cossarizza, A. (2016) · European Journal of Immunology · doi:10.1002/eji.201546178 · Cited by 439
Self-citationImmune activation and HIV persistence: implications for curative approaches to HIV infection
Klatt, N. R., Chomont, N., Douek, D. C., & Deeks, S. G. (2013) · Immunological Reviews · doi:10.1111/imr.12065 · Cited by 435
“More specifically, a higher than expected frequency of activated cells is specific for persistent herpes virus antigens (142, 219).”
BackgroundHIV and Inflammation: Mechanisms and Consequences
Hunt, P. W. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0118-8 · Cited by 417
“specific T cells and activation and expansion of non-HIVspecific T cells has been clearly documented during early HIV infection [9, 10].”
T‐cell exhaustion in HIV infection
Fenwick, C., Joo, V., Jacquier, P., Noto, A., Banga, R., Perreau, M., & Pantaleo, G. (2019) · Immunological Reviews · doi:10.1111/imr.12823 · Cited by 425
Wikby, A., Ferguson, F., Forsey, R., Thompson, J., Strindhall, J., Löfgren, S., Nilsson, B.-O., Ernerudh, J., Pawelec, G., & Johansson, B. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.5.556 · Cited by 407
Four functionally distinct populations of human effector-memory CD8+ T lymphocytes
Romero, P., Zippelius, A., Kurth, I., Pittet, M. J., Touvrey, C., Iancu, E. M., Corthesy, P., Devevre, E., Speiser, D. E., & Rufer, N. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4112 · Cited by 405
“This agrees with our recently published results (12) showing progressive shortening of the telomeres along T cell differentiation, so that highly differentiated CD8 CCR7 CD27 CD57 cells displayed the shortest telomeres, with lengths equivalent to those observed in primed CD8 T cells from the elderly (22).”
ResultSelf-citationChew, G. M., Fujita, T., Webb, G. M., Burwitz, B. J., Wu, H. L., Reed, J. S., Hammond, K. B., Clayton, K. L., Ishii, N., Abdel-Mohsen, M., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005349 · Cited by 323
T Cell Replicative Senescence in Human Aging
P. Chou, J., & B. Effros, R. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805219711 · Cited by 323
Predictive Value of Plasma HIV RNA Level on Rate of CD4 T-Cell Decline in Untreated HIV Infection
Rodríguez, B., Sethi, A. K., Cheruvu, V. K., Mackay, W., Bosch, R. J., Kitahata, M., Boswell, S. L., Mathews, W. C., Bangsberg, D. R., Martin, J., et al. (2006) · JAMA · doi:10.1001/jama.296.12.1498 · Cited by 320
“Age, y† 36 (31-42) 36 (30-41) 34 (30-41) 36 (30-41) 36 (31-42) 36 (31-41)”
Hinrichs, C. S., Borman, Z. A., Gattinoni, L., Yu, Z., Burns, W. R., Huang, J., Klebanoff, C. A., Johnson, L. A., Kerkar, S. P., Yang, S., et al. (2011) · Blood · doi:10.1182/blood-2010-05-286286 · Cited by 307
CD57 in human natural killer cells and T-lymphocytes
Kared, H., Martelli, S., Ng, T. P., Pender, S. L. F., & Larbi, A. (2016) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-016-1803-z · Cited by 306
Hsue, P. Y., Hunt, P. W., Sinclair, E., Bredt, B., Franklin, A., Killian, M., Hoh, R., Martin, J. N., McCune, J. M., Waters, D. D., et al. (2006) · AIDS · doi:10.1097/qad.0b013e3280108704 · Cited by 284
“This phenomenon, which appears to be linked to the effect of HIV on immune activation [13], directly contributes to the progressive CD4 T-cell depletion, perhaps as a consequence of increased rates of T-cell maturation and death and/or decreased rates of de novo T-cell production [14–16].”
BackgroundFunctional Significance of CD57 Expression on Human NK Cells and Relevance to Disease
Nielsen, C. M., White, M. J., Goodier, M. R., & Riley, E. M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00422 · Cited by 282
“In light of the T cell data it was suggested that CD57 may also be a marker of NK cells with poor proliferative capacity and, perhaps, a degree of immunosenescence (21, 23, 28).”
BackgroundNehme, N. T., Schmid, J. P., Debeurme, F., André-Schmutz, I., Lim, A., Nitschke, P., Rieux-Laucat, F., Lutz, P., Picard, C., Mahlaoui, N., et al. (2012) · Blood · doi:10.1182/blood-2011-09-378364 · Cited by 283
Evidence of premature immune aging in patients thymectomized during early childhood
Sauce, D., Larsen, M., Fastenackels, S., Duperrier, A., Keller, M., Grubeck-Loebenstein, B., Ferrand, C., Debré, P., Sidi, D., & Appay, V. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39269 · Cited by 278
“CD57 expression is considered a marker of T cell replicative history, identifying cells that approach senescence (15, 16).”
BackgroundSelf-citationImmune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway
Bowers, N. L., Helton, E. S., Huijbregts, R. P. H., Goepfert, P. A., Heath, S. L., & Hel, Z. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003993 · Cited by 256
“CD57 is expressed primarily on T cells at late or terminal stages of differentiation and marks a state of replicative senescence characterized by a loss of the proliferative and target cell killing capacity [35,36].”
BackgroundGuadalupe, M., Sankaran, S., George, M. D., Reay, E., Verhoeven, D., Shacklett, B. L., Flamm, J., Wegelin, J., Prindiville, T., & Dandekar, S. (2006) · Journal of Virology · doi:10.1128/jvi.00120-06 · Cited by 251
“Antiviral CD8 cytotoxic T-cell responses in mucosal tissues of HIV-infected patients have been shown to produce high levels of granzyme A but low levels of perforin (36), suggesting that HIV-specific CD8 T-cell responses may not be fully functional in chronically infected patients (4, 5, 9, 20, 30 ).”
BackgroundDNA as a Versatile Chemical Component for Catalysis, Encoding, and Stereocontrol
Silverman, S. K. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906345 · Cited by 243
Accelerated immune senescence and HIV-1 infection
APPAY, V, ALMEIDA, J., SAUCE, D., AUTRAN, B., & PAPAGNO, L. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2006.12.003 · Cited by 236
Self-citationInflammation, immune activation, and cardiovascular disease in HIV
Nou, E., Lo, J., & Grinspoon, S. K. (2016) · AIDS · doi:10.1097/qad.0000000000001109 · Cited by 231
“Non-HIV-specific T-cell activation has been observed and the frequency of activated CD8þ T cells is greater than the frequency of HIV-specific T cells [52,53].”
BackgroundLineage relationship of effector and memory T cells
Restifo, N. P., & Gattinoni, L. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.09.003 · Cited by 228
“This view, however, is at odds with the findings that length of telomeres [23–25] and activity of telomerase [25] are both reduced in effector compared to memory cells.”
ResultEmu, B., Sinclair, E., Favre, D., Moretto, W. J., Hsue, P., Hoh, R., Martin, J. N., Nixon, D. F., McCune, J. M., & Deeks, S. G. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14169-14178.2005 · Cited by 215
“immune activation (32), which directly contributes to progres-”
BackgroundNaeger, D. M., Martin, J. N., Sinclair, E., Hunt, P. W., Bangsberg, D. R., Hecht, F., Hsue, P., McCune, J. M., & Deeks, S. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008886 · Cited by 190
“Early HIV infection was associated with higher frequencies of pp65-specific CD8+ T cell responses (as compared to HIV seronegatives), confirming previous reports [41,42].”
ResultMechanisms Underlying T Cell Immunosenescence: Aging and Cytomegalovirus Infection
Tu, W., & Rao, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02111 · Cited by 189
Immune checkpoint inhibitors and elderly people: A review
Daste, A., Domblides, C., Gross-goupil, M., Chakiba, C., Quivy, A., Cochin, V., de Mones, E., Larmonier, N., Soubeyran, P., & Ravaud, A. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.05.044 · Cited by 188
DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice
Randall, K. L., Chan, S. S.-Y., Ma, C. S., Fung, I., Mei, Y., Yabas, M., Tan, A., Arkwright, P. D., Al Suwairi, W., Lugo Reyes, S. O., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110345 · Cited by 190
“Furthermore, these molecules were up- or Furthermore, in the setting of chronic viral infection, these cells may have undergone replicative senescence (Chen et al., 2001; Brenchley et al., 2003; Papagno et al., 2004; Plunkett et al., 2005).”
BackgroundResultInfluentialT cell-mediated immune responses in human newborns: ready to learn?
Marchant, A., & Goldman, M. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02799.x · Cited by 183
Self-citationAppay, V., Fastenackels, S., Katlama, C., Ait-Mohand, H., Schneider, L., Guihot, A., Keller, M., Grubeck-Loebenstein, B., Simon, A., Lambotte, O., et al. (2011) · AIDS · doi:10.1097/qad.0b013e32834640e6 · Cited by 167
Self-citationPathogenic mechanisms of B-lymphocyte dysfunction in HIV disease
Moir, S., & Fauci, A. S. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.034 · Cited by 163
Thimme, R., Appay, V., Koschella, M., Panther, E., Roth, E., Hislop, A. D., Rickinson, A. B., Rowland-Jones, S. L., Blum, H. E., & Pircher, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.12112-12116.2005 · Cited by 166
“By using KLRG1 as a marker, our results suggest that persistent viral antigen stimulation leads to T cells with impaired proliferative capacity and that this is a general feature of virus-specific CD8 T cells in chronic infections ( 23 , 26).”
ResultSelf-citationImmune activation in the course of HIV‐1 infection: Causes, phenotypes and persistence under therapy
Younas, M., Psomas, C., Reynes, J., & Corbeau, P. (2016) · HIV Medicine · doi:10.1111/hiv.12310 · Cited by 159
Deeks, S. G., Verdin, E. M., & McCune, J. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.05.004 · Cited by 181
CXCR5+ CCR7– CD8 T cells are early effector memory cells that infiltrate tonsil B cell follicles
Quigley, M. F., Gonzalez, V. D., Granath, A., Andersson, J., & Sandberg, J. K. (2007) · European Journal of Immunology · doi:10.1002/eji.200636746 · Cited by 160
Palmer, B. E., Blyveis, N., Fontenot, A. P., & Wilson, C. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8415 · Cited by 159
“The expression of CD57 on the surface of CD8 T cells is also linked with chronic immune activation, and increased numbers of CD8 T cells expressing CD57 have been associated with HIV-1 and other persistent viral infections (7, 9, 10).”
BackgroundImmune modulation during latent herpesvirus infection
White, D. W., Beard, R. S., & Barton, E. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01074.x · Cited by 186
Appay, V., Jandus, C., Voelter, V., Reynard, S., Coupland, S. E., Rimoldi, D., Líénard, D., Guillaume, P., Krieg, A. Μ., Cerottini, J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1670 · Cited by 152
“Therefore, the possibility for a cancer vaccine to drive tumor-specific T cells to display phenotype similar to that of cells specific for these two persistent viruses may be an encouraging sign of efficacy and suggests a strong level of stimulation (22, 23).”
BackgroundSelf-citationT-Cell Immunity to Infection with Dengue Virus in Humans
Weiskopf, D., & Sette, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00093 · Cited by 150
“Markers such as CD57 (73, 74), CD40L (75), and PD-1 (programed death-1) (76) allow determination of activation/exhaustion states of memory T-cell subsets.”
BackgroundTrypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients
Albareda, M. C., Laucella, S. A., Alvarez, M. G., Armenti, A., Bertocchi, G. L., Tarleton, R. L., & Postan, M. (2006) · International Immunology · doi:10.1093/intimm/dxh387 · Cited by 149
“T cells, with reduced proliferation capacity and low T cell competence, have been documented in other persistent infections ( 20 ).”
BackgroundRole of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.
Dock, J., & Effros, R. B. (2011) · Europe PMC (PubMed Central) · Cited by 164
Lessons from the study of T-cell differentiation in persistent human virus infection
Appay, V., & Rowland‐Jones, S. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.02.007 · Cited by 158
Self-citationPremature Aging of T cells Is Associated With Faster HIV-1 Disease Progression
Cao, W., Jamieson, B. D., Hultin, L. E., Hultin, P. M., Effros, R. B., & Detels, R. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181926c28 · Cited by 144
“Our finding is in keeping with a previous report, which documented that HIV-1–infected nonprogressors had fewer late-stage T cells than progressors.(26) Accumulating evidence has shown that the process of T-cell senescence is a component of the T-cell differentiation pathway, as terminally differentiated cells share c…”
BackgroundResultKinter, A. L., Horak, R., Sion, M., Riggin, L., McNally, J. P., Lin, Y., Jackson, R. W., O'Shea, A., Roby, G. A., Kovacs, C. M., et al. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0162 · Cited by 126
The physiological role of cytotoxic CD4+ T-cells: the holy grail?
Appay, V. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02605.x · Cited by 127
Self-citationParrinello, C. M., Sinclair, E., LANDAY, A. L., Lurain, N. S., Sharrett, A. R., Gange, S. J., Xue, X., Hunt, P. W., Deeks, S. G., Hodis, H. N., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis276 · Cited by 125
AGEhIV Study Group, Jiménez, V. C., Wit, F. W. N. M., Joerink, M., Maurer, I., Harskamp, A. M., Schouten, J., Prins, M., van Leeuwen, E. M. M., Booiman, T., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw146 · Cited by 142
Boasso, A., Hardy, A. W., Anderson, S. A., Dolan, M. J., & Shearer, G. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002961 · Cited by 137
“The reactivation of latent viral infections, such as CMV or EBV, due to the reduction of immune control, as well as the occurrence of other opportunistic infections, may also provide further antigenic stimulation to T cells [23–26].”
BackgroundSharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
Peng, X., Ouyang, J., Isnard, S., Lin, J. C.-Y., Fombuena, B., Zhu, B., & Routy, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.596631 · Cited by 134
“The expressions of CD38 and HLA-DR as well as programmed death -1 (PD-1) are biomarkers of activated T cells, contributing to T cell exhaustion (36).”
BackgroundO’Brien, M. P., Manches, O., Sabado, R. L., Baranda, S. J., Wang, Y., Marie, I., Rolnitzky, L. M., Markowitz, M. H., Margolis, D. M., Levy, D. E., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44960 · Cited by 146
Sacré, K., Carcelain, G., Cassoux, N., Fillet, A., Costagliola, D. G., Vittecoq, D., Salmon, D., Amoura, Z., Katlama, C., & Autran, B. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042408 · Cited by 120
“The reinforcement of the HCMV-specific CD27 / CD28 CD8 T cells, after recovery from retinitis to levels similar to those observed in healthy individuals, suggests that these cells, with a known higher proliferation ability (25, 31, 48), play a key protective role in ensuring stable control of HCMV replication.”
BackgroundThe Immune Response toMycobacterium tuberculosisin HIV-1-Coinfected Persons
Esmail, H., Riou, C., Bruyn, E. D., Lai, R., Harley, Y. X. R., Meintjes, G., Wilkinson, K. A., & Wilkinson, R. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053420 · Cited by 148
Elevation and persistence of CD8 T‐cells in HIV infection: the Achilles heel in the ART era
Cao, W., Mehraj, V., Kaufmann, D., Li, T., & Routy, J. (2016) · Journal of the International AIDS Society · doi:10.7448/ias.19.1.20697 · Cited by 124
“However, the role of HIV in immunosenescence remains controversial, as most of the detected senescent CD8 T-cells are CMV-specific, which are already identified per se as a risk factor of immunosenescence [64].”
BackgroundPetrovas, C., Chaon, B., Ambrozak, D. R., Price, D. A., Melenhorst, J. J., Hill, B. J., Geldmacher, C., Casazza, J. P., Chattopadhyay, P. K., Roederer, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900182 · Cited by 126
“licative senescence in HIV infection (27, 28).”
Goicoechea, M., Smith, D. M., Liu, L., May, S. J., Tenorio, A. R., Ignacio, C. C., LANDAY, A. L., & Haubrich, R. (2006) · The Journal of Infectious Diseases · doi:10.1086/504718 · Cited by 114
“both aging and HIV-1 infection accelerate depletion [30, 38].”
BackgroundCD57+ CD4 T cells underlie belatacept-resistant allograft rejection
Espinosa, J., Herr, F., Tharp, G., Bosinger, S., Song, M.-Q., Farris, A., George, R. P., Cheeseman, J., Stempora, L., Townsend, R., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13613 · Cited by 111
Immune activation and cardiovascular disease in chronic HIV infection
Longenecker, C. T., Sullivan, C., & Baker, J. V. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000227 · Cited by 121
“Concurrent with CD4þ depletion, high-level and persistent CD8þ T-cell activation is a key feature of the natural history of HIV infection [30].”
BackgroundCastilho, J. L., Shepherd, B. E., Koethe, J. R., Turner, M. M., Bebawy, S. S., Logan, J., Rogers, W. B., Raffanti, S. P., & Sterling, T. R. (2015) · AIDS · doi:10.1097/qad.0000000000001005 · Cited by 112
Mechanisms of CD8 + T cell‐mediated suppression of HIV/SIV replication
McBrien, J. B., Kumar, N., & Silvestri, G. (2018) · European Journal of Immunology · doi:10.1002/eji.201747172 · Cited by 125
Viral strategies for evading antiviral cellular immune responses of the host
Iannello, A., Débbeche, O., Martin, É., Attalah, L., Samarani, S., & Ahmad, A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705397 · Cited by 109
“The lack of help from CD4 T cells is probably one of the reasons for incomplete differentiation of HIV-specific CTL in HIV-infected individuals [145, 146].”
BackgroundTakata, H., Buranapraditkun, S., Kessing, C. F., Fletcher, J. L. K., Muir, R., Tardif, V., Cartwright, P., Vandergeeten, C., Bakeman, W., Nichols, C. N., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1809 · Cited by 123
Haas, A., Zimmermann, K., & Oxenius, A. (2011) · Journal of Virology · doi:10.1128/jvi.05607-11 · Cited by 111
Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection
Duvall, M. G., Jaye, A., Dong, T., Brenchley, J. M., Alabi, A. S., Jeffries, D. J., van der Sande, M. A. B., Togun, T. O., McConkey, S. J., Douek, D. C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6973 · Cited by 109
Self-citationIsolation of High‐Affinity Trypsin Inhibitors from a DNA‐Encoded Chemical Library
Melkko, S., Zhang, Y., Dumelin, C. E., Scheuermann, J., & Neri, D. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700654 · Cited by 104
Impact of HIV on CD8+ T Cell CD57 Expression Is Distinct from That of CMV and Aging
Lee, S. A., Sinclair, E., Hatano, H., Hsue, P. Y., Epling, L., Hecht, F. M., Bangsberg, D. R., Martin, J. N., McCune, J. M., Deeks, S. G., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089444 · Cited by 112
“population in HIV infection [4,5], but much of this increase could be explained by relative enrichment for effector CD28- CD8+ T cells over central memory and naı̈ve CD8+ T cells (which rarely express CD57).”
BackgroundEdwards, E. S. J., Bier, J., Cole, T. S., Wong, M., Hsu, P. S., Berglund, L. J., Boztuǧ, K., Lau, A., Emma Gostick, D., Price, D. A., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.04.030 · Cited by 101
“To achieve this, we quantified expression of surface molecules associated with CD8(1) T-cell activation (CD38, HLA class I, and HLA class II),(39,40) differentiation, exhaustion (CD95, CD160, KLRG1, and PD-1),(38,41-45) and senescence (CD57).(35,36) The proportions of total PIK3CD GOF CD8(1) T cells that expressed the…”
BackgroundCD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy
Perdomo-Celis, F., Taborda, N. A., & Rugeles, M. T. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01896 · Cited by 117
Koesters, S. A., Alimonti, J. B., Wachihi, C., Matu, L., Anzala, O. A., Kimani, J., Embree, J. E., Plummer, F. A., & Fowke, K. R. (2006) · European Journal of Immunology · doi:10.1002/eji.200535111 · Cited by 96
Yuen, L. H., & Franzini, R. M. (2016) · ChemBioChem · doi:10.1002/cbic.201600567 · Cited by 94
HIV controllers: how do they tame the virus?
Sáez‐Cirión, A., Pancino, G., Sinet, M., Venet, A., & Lambotte, O. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.09.002 · Cited by 99
Aging and HIV/AIDS: pathogenetic role of therapeutic side effects
Torres, R. A., & Lewis, W. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.142 · Cited by 111
Contribution of Herpesvirus Specific CD8 T Cells to Anti-Viral T Cell Response in Humans
Sandalova, E., Laccabue, D., Boni, C., Tan, A. T., Fink, K., Ooi, E. E., Chua, R. L., Shafaeddin-Schreve, B., Ferrari, C. I., & Bertoletti, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001051 · Cited by 108
“Of note, the presence of activated HCMV and EBV specific CD8 was also detected during other pathological human viral infections [14,26,27] further supporting our conclusion that activation of CD8 T cells specific for persistent infection is a consistent phenomenon during symptomatic viral infections.”
ResultBreton, G., Chomont, N., Takata, H., Fromentin, R., Ahlers, J. D., Filali-Mouhim, A., Riou, C., Boulassel, M., Routy, J., Yassine‐Diab, B., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1200646 · Cited by 107
Immune activation and immune aging in HIV infection
Appay, V., & Kelleher, A. D. (2016) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000240 · Cited by 92
“These T-cell subsets are characterized by a reduced capacity to produce IL-2 and to proliferate, and shortened telomere lengths, so that highly differentiated cells (CD28 /CD57þ) have been considered as end-stage senescent cells [27,28].”
BackgroundSelf-citationT-cell exhaustion in HIV infection
Far, M. E., Halwani, R., Said, E. A., Trautmann, L., Doroudchi, M., Janbazian, L., Fonseca, S. G., van Grevenynghe, J., Yassine‐Diab, B., Sékaly, R., et al. (2008) · Current HIV/AIDS Reports · doi:10.1007/s11904-008-0003-7 · Cited by 105
“This hyperimmune activation, which compromises the homeostatic process, has been suggested to be responsible for the slow depletion of CD4 T cells and the clonal senescence of CD8 T cells [10, 11 ].”
BackgroundSacré, K., Hunt, P. W., Hsue, P. Y., Maidji, E., Martin, J. N., Deeks, S. G., Autran, B., & McCune, J. M. (2012) · AIDS · doi:10.1097/qad.0b013e328351f780 · Cited by 88
“Accordingly, we observed that CD4þCX3CR1þ T cells predominantly expressed CD57þ, an antigen-primed marker highly expressed on CMV-specific T cells [25,26].”
BackgroundZaunders, J., Munier, C. M. L., Kaufmann, D., Ip, S., Grey, P., Smith, D. E., Ramacciotti, T., Quan, D., Finlayson, R. J., Kaldor, J. M., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0206 · Cited by 89
Lymphopenia-driven homeostatic regulation of naive T cells in elderly and thymectomized young adults
Sauce, D., Larsen, M., Fastenackels, S., Roux, A., Gorochov, G., Katlama, C., Sidi, D., Sibony-Prat, J., & Appay, V. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201235 · Cited by 82
“2A), as this is usually observed for the memory compartment (data not shown) (27, 28).”
BackgroundSelf-citationLiving in a house of cards: re‐evaluating CD8+ T‐cell immune correlates against HIV
Makedonas, G., & Betts, M. R. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00968.x · Cited by 96
“The relevance of HLA-DR and Ki67 (the classically used indicators of immune activation) on HIV-specific CD8 T cells is doubtful, however, as HIV-specific CD8 T cells in chronic infection rarely express these markers despite widespread immune activation in the host at this stage of infection (97).”
Backgroundand the CAPRISA 002 Acute Infection Study Team, Burgers, W. A., Riou, C., Mlotshwa, M., Maenetje, P. W., Rosa, D. D. A., Brenchley, J. M., Mlisana, K. P., Douek, D. C., Koup, R. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803801 · Cited by 93
“immune activation has previously been proposed (40).”
BackgroundKovács, A., Al‐Harthi, L., Christensen, S., Mack, W. J., Cohen, M. H., & LANDAY, A. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/587696 · Cited by 80
“Activation of T cells occurs following antigen presentation, and the level of activation is related to the antigen load [9–11].”
BackgroundSauce, D., Dong, Y., Campillo-Gimenez, L., Casulli, S., Bayard, C., Autran, B., Boddaert, J., Appay, V., & Elbim, C. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw062 · Cited by 93
“As expected (32–34), they displayed standard evidence of age-related immune alterations illustrated by the accumulation of highly differentiated CD8+ and CD4+ memory cells (Tem: CD45RA-CCR7− and Tcm: CD45RA-CCR7+) expressing increased levels of CD57, a marker that has been associated with a state of replicative senesc…”
BackgroundSelf-citationMassey, J. C., Sutton, I. J., Ma, D. D. F., & Moore, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00410 · Cited by 89
Metadata
- Authors
- Papagno, L., Spina, C. A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T., Chesney, G., Waters, A., Easterbrook, P., Dunbar, P. R., Shepherd, D., Cerundolo, V., Emery, V., Griffiths, P., Conlon, C., McMichael, A. J., Richman, D. D., Rowland-Jones, S. L., & Appay, V.
- Affiliations
- University of Milan (IT)
- University of California San Diego (US)
- John Radcliffe Hospital (GB)
- The Royal Free Hospital (GB)
- ORCID
- Venue
- PLoS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2004-02-17
- Volume
- 2
- Issue
- 2
- Pages
- e20
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC340937
- OpenAlex
- W1965845165
- Cited by
- 478
- References
- 71
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 14 · 2023: 10 · 2022: 20 · 2021: 18 · 2020: 13 · 2019: 20 · 2018: 22 · 2017: 21 · 2016: 29 · 2015: 23 · 2014: 22 · 2013: 28 · 2012: 31
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Cancer Research UK
- King's College London
- European Commission (QLK2-CT)
- National Institutes of Health
- Center for AIDS Research, University of Washington
- University of California, San Diego
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (AI-29164, R24AI106039, R37AI029164)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- HIV-1 infection, immune activation, CD8+ T cell differentiation, replicative senescence, T cell exhaustion, acute HIV-1 infection, disease progression, CD4+ T cells, virus-specific T cells, T cell priming, immunodeficiency
- MeSH terms
- Aging, Cell Differentiation, Humans, Lymphocyte Activation, CD4-Positive T-Lymphocytes, HIV Infections, CD8-Positive T-Lymphocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.